Nation’s Top HIV Funders Announce Historic Partnership, Game Changing Investment in U.S. South
Nation’s Top HIV Funders Announce Historic Partnership, Game Changing Investment in U.S. South
New Fund to provide $2.65 million in grants to accelerate progress toward ending HIV and reducing health disparities
WASHINGTON, DC – Today, Gilead Sciences, Ford Foundation, Elton John AIDS Foundation, ViiV Healthcare, and Johnson & Johnson – leading funders of the domestic HIV response – launched a first-of-its-kind collaborative, The Southern HIV Impact Fund (The Fund) to stop the persistent and worsening impact of the epidemic on the region. The Fund is making an initial investment of $2.65 million in support of 37 organizations in nine states: Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas. It has already mobilized an additional $150,000 in emergency support for people living with HIV in hurricane-impacted areas of the region, including Texas and Florida.
Funders Concerned About AIDS (FCAA) convened the collaborative to accelerate meaningful progress toward ending HIV and reducing health disparities in the South. AIDS United, the nation’s leading organization working to end the HIV/AIDS epidemic in the U.S. and with a long history of investing in the South, is managing the fund.